FOLH1 and prostate carcinoma: Hypothetically, cold J591 or derivatives with a smaller molecular weight co-injected with [177Lu]-PSMA-617 may increase the internalization rate of [177Lu]-PMSA and [68Ga]-PSMA-HBEDC in prostate carcinoma tissue, thereby reducing uptake in healthy tissue, e.g., the salivary glands.